A 12-year-old boy from Tamil Nadu with a history of acute rheumatic fever 18 months ago is brought to the clinic for routine follow-up. He has been on regular benzathine penicillin G prophylaxis. On examination, he has a diastolic murmur at the apex and a systolic murmur at the left sternal border. Echocardiography shows severe mitral stenosis with a mitral valve area of 0.8 cm², moderate aortic regurgitation, and left atrial enlargement. He is currently asymptomatic. What is the most appropriate next step in management?

Explanation

## Management of Chronic Rheumatic Heart Disease in Asymptomatic Child ### Clinical Context This child has **established chronic rheumatic heart disease (CRHD)** with: - **Severe mitral stenosis** (MVA 0.8 cm²; normal >4 cm²) - **Moderate aortic regurgitation** - **Left atrial enlargement** (consequence of mitral stenosis) - **Currently asymptomatic** — no dyspnea, palpitations, or syncope ### Key Point: **In asymptomatic severe CRHD, medical management and continued prophylaxis are standard. Valve intervention is reserved for symptomatic disease, hemodynamic deterioration, or development of complications (atrial fibrillation, thromboembolic events, left ventricular dysfunction).** ### Management Strategy | Aspect | Action | Rationale | |--------|--------|----------| | **Secondary prophylaxis** | Continue benzathine penicillin G 1.2 MU IM q3–4 weeks | Prevents recurrent GAS pharyngitis and further valve damage; indicated until age 21 (minimum 5 years post-ARF, longer if carditis present) | | **Surgical intervention** | Defer unless symptomatic or hemodynamic decompensation | Prosthetic valves have limited durability in children; reoperation burden is high | | **Monitoring** | Regular clinical assessment + annual echocardiography | Detect progression, arrhythmias, or development of left ventricular dysfunction | | **Activity** | Unrestricted in asymptomatic state | No need for activity restriction if hemodynamically stable | | **Anticoagulation** | Not indicated unless atrial fibrillation develops | Risk of thromboembolism rises with AF | ### High-Yield: **Indications for mitral valve intervention in CRHD:** - **Symptomatic** (dyspnea, reduced exercise tolerance, syncope) - **Hemodynamic markers:** Pulmonary hypertension (systolic PAP >60 mmHg), left ventricular dysfunction (EF <50%), new-onset atrial fibrillation - **Pregnancy planning** in women with severe stenosis - **Asymptomatic severe stenosis** is NOT an automatic indication for surgery in children ### Why Penicillin Prophylaxis Continues **Secondary prophylaxis duration in CRHD:** - Minimum 5 years from last ARF episode - Until age 21 years (or longer if carditis was present) - Lifelong if recurrent ARF or progressive valve disease This child is only 18 months post-ARF and <21 years old → continue prophylaxis. ### Monitoring Plan 1. **Clinical:** Assess for symptoms (dyspnea, palpitations, syncope) at each visit 2. **ECG:** Screen for atrial fibrillation 3. **Echocardiography:** Annual or biennial to track valve area, ventricular function, PAP 4. **Dental care:** Antibiotic prophylaxis for dental procedures (if indicated by local guidelines) [cite:Park 26e Ch 3; Harrison 21e Ch 320]